Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Interferon beta-1a fbs-free/hsa free, rnf	Human interferon beta	[1] D04554 💬	[2] IFNAR1, IFNAR2 💬	[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	[1] 13 💬
2	Interferon beta-1a fbs-free/hsa-free, rnf	Human interferon beta	[1] D04554 💬	[2] IFNAR1, IFNAR2 💬	[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	[1] 13 💬
3	Interferon-beta 1a fbs-free/hsa free, rnf	Human interferon beta	-	-	-	[1] 13 💬
4	Interferon-beta 1a fbs-free/hsa-free, rnf	Human interferon beta	-	-	-	[1] 13 💬
5	Interferon-beta-1a fbs-free/hsa free, rnf	Human interferon beta	[1] D04554 💬	[2] IFNAR1, IFNAR2 💬	[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway	[1] 13 💬
6	Rebif® new formulation (ifn-beta-1a, rnf)	-	-	-	-	[1] 13 💬
7	Rebif® new formulation (rnf)	-	-	-	-	[1] 13 💬
8	Rebif® new formulation (rnf) using rebismarttm	-	-	-	-	[1] 13 💬
9	Rnf	-	-	-	-	[1] 13 💬